Skip to main content

Table 5 Incremental cost-effectiveness ratios of pregabalin vs. gabapentin in the treatment of painful DPN and PHN

From: Pregabalin versus gabapentin in the management of peripheral neuropathic pain associated with post-herpetic neuralgia and diabetic neuropathy: a cost effectiveness analysis for the Greek healthcare setting

 

Pregabalin vs Gabapentin

Cost per additional (€)

Mean (95% CI)

Day with no or mild pain

     Mean estimate

13

     95% confidence interval

(8, 18)

QALY gained

     Mean estimate

19,320

     95% confidence interval

(11,743 - 26,755)